Figure 5From: JMJD2A contributes to breast cancer progression through transcriptional repression of the tumor suppressor ARHIInteractions between JMJD2A, E2F1, E2F4, histone deacetylase (HDAC)1 and HDAC3. (A) JMJD2A could immunoprecipitate E2F1, E2F4, HDAC1 and HDAC3. (B) JMJD2A could be immunoprecipitated by E2F1 with anti-E2F1 antibody. (C) JMJD2A could be immunoprecipitated by E2F4 with anti-E2F4 antibody. IP, immunoprecipation; Ab, antibody.Back to article page